Literature DB >> 22290433

Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1α/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice.

Aparna Purushotham1, Qing Xu, Jing Lu, Julie F Foley, Xingjian Yan, Dong-Hyun Kim, Jongsook Kim Kemper, Xiaoling Li.   

Abstract

SIRT1, a highly conserved NAD(+)-dependent protein deacetylase, is a key metabolic sensor that directly links nutrient signals to animal metabolic homeostasis. Although SIRT1 has been implicated in a number of hepatic metabolic processes, the mechanisms by which hepatic SIRT1 modulates bile acid metabolism are still not well understood. Here we report that deletion of hepatic SIRT1 reduces the expression of farnesoid X receptor (FXR), a nuclear receptor that regulates bile acid homeostasis. We provide evidence that SIRT1 regulates the expression of FXR through hepatocyte nuclear factor 1α (HNF1α). SIRT1 deficiency in hepatocytes leads to decreased binding of HNF1α to the FXR promoter. Furthermore, we show that hepatocyte-specific deletion of SIRT1 leads to derangements in bile acid metabolism, predisposing the mice to development of cholesterol gallstones on a lithogenic diet. Taken together, our findings indicate that SIRT1 plays a vital role in the regulation of hepatic bile acid homeostasis through the HNF1α/FXR signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22290433      PMCID: PMC3302441          DOI: 10.1128/MCB.05988-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP.

Authors:  Amy K Walker; Fajun Yang; Karen Jiang; Jun-Yuan Ji; Jennifer L Watts; Aparna Purushotham; Olivier Boss; Michael L Hirsch; Scott Ribich; Jesse J Smith; Kristine Israelian; Christoph H Westphal; Joseph T Rodgers; Toshi Shioda; Sarah L Elson; Peter Mulligan; Hani Najafi-Shoushtari; Josh C Black; Jitendra K Thakur; Lisa C Kadyk; Johnathan R Whetstine; Raul Mostoslavsky; Pere Puigserver; Xiaoling Li; Nicholas J Dyson; Anne C Hart; Anders M Näär
Journal:  Genes Dev       Date:  2010-07-01       Impact factor: 11.361

2.  SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism.

Authors:  Bhaskar Ponugoti; Dong-Hyun Kim; Zhen Xiao; Zachary Smith; Ji Miao; Mengwei Zang; Shwu-Yuan Wu; Cheng-Ming Chiang; Timothy D Veenstra; Jongsook Kim Kemper
Journal:  J Biol Chem       Date:  2010-09-03       Impact factor: 5.157

3.  A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition.

Authors:  Jiyoung Lee; Amruta Padhye; Abhilasha Sharma; Guisheng Song; Ji Miao; Yin-Yuan Mo; Li Wang; Jongsook Kim Kemper
Journal:  J Biol Chem       Date:  2010-02-25       Impact factor: 5.157

4.  Liver steatosis and increased ChREBP expression in mice carrying a liver specific SIRT1 null mutation under a normal feeding condition.

Authors:  Rui-Hong Wang; Cuiling Li; Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2010-11-16       Impact factor: 6.580

Review 5.  Hepatic nuclear factor 1-alpha: inflammation, genetics, and atherosclerosis.

Authors:  Angela D Armendariz; Ronald M Krauss
Journal:  Curr Opin Lipidol       Date:  2009-04       Impact factor: 4.776

6.  FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states.

Authors:  Jongsook Kim Kemper; Zhen Xiao; Bhaskar Ponugoti; Ji Miao; Sungsoon Fang; Deepthi Kanamaluru; Stephanie Tsang; Shwu-Yuan Wu; Cheng-Ming Chiang; Timothy D Veenstra
Journal:  Cell Metab       Date:  2009-11       Impact factor: 27.287

Review 7.  Mammalian sirtuins: biological insights and disease relevance.

Authors:  Marcia C Haigis; David A Sinclair
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

8.  Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1.

Authors:  Elhadji M Dioum; Rui Chen; Matthew S Alexander; Quiyang Zhang; Richard T Hogg; Robert D Gerard; Joseph A Garcia
Journal:  Science       Date:  2009-06-05       Impact factor: 47.728

9.  Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1.

Authors:  Sandy D Westerheide; Julius Anckar; Stanley M Stevens; Lea Sistonen; Richard I Morimoto
Journal:  Science       Date:  2009-02-20       Impact factor: 47.728

10.  SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages.

Authors:  Ran Zhang; Hou-Zao Chen; Jin-Jing Liu; Yu-Yan Jia; Zhu-Qin Zhang; Rui-Feng Yang; Yuan Zhang; Jing Xu; Yu-Sheng Wei; De-Pei Liu; Chih-Chuan Liang
Journal:  J Biol Chem       Date:  2009-12-30       Impact factor: 5.157

View more
  30 in total

1.  Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis.

Authors:  Supriya R Kulkarni; Carol J Soroka; Lee R Hagey; James L Boyer
Journal:  Hepatology       Date:  2016-10-28       Impact factor: 17.425

Review 2.  A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis.

Authors:  Brandy Garzel; Lei Zhang; Shiew-Mei Huang; Hongbing Wang
Journal:  Curr Drug Metab       Date:  2019       Impact factor: 3.731

3.  18β-Glycyrrhetinic acid protects against alpha-naphthylisothiocyanate-induced cholestasis through activation of the Sirt1/FXR signaling pathway.

Authors:  Shou-Yan Wu; Shi-Chao Cui; Le Wang; Yi-Ting Zhang; Xiao-Xia Yan; Heng-Lei Lu; Guo-Zhen Xing; Jin Ren; Li-Kun Gong
Journal:  Acta Pharmacol Sin       Date:  2018-07-30       Impact factor: 6.150

Review 4.  Emerging role of silent information regulator 1 (SIRT1) in hepatocellular carcinoma: a potential therapeutic target.

Authors:  Yuting Wu; Xiaoming Meng; Cheng Huang; Jun Li
Journal:  Tumour Biol       Date:  2015-05-01

5.  Intestine-specific deletion of SIRT1 in mice impairs DCoH2-HNF-1α-FXR signaling and alters systemic bile acid homeostasis.

Authors:  Nevzat Kazgan; Mallikarjuna R Metukuri; Aparna Purushotham; Jing Lu; Anuradha Rao; Sangkyu Lee; Matthew Pratt-Hyatt; Andrew Lickteig; Iván L Csanaky; Yingming Zhao; Paul A Dawson; Xiaoling Li
Journal:  Gastroenterology       Date:  2013-12-31       Impact factor: 22.682

6.  Celastrol Protects From Cholestatic Liver Injury Through Modulation of SIRT1-FXR Signaling.

Authors:  Qi Zhao; Fang Liu; Yan Cheng; Xue-Rong Xiao; Dan-Dan Hu; Ying-Mei Tang; Wei-Min Bao; Jin-Hui Yang; Tao Jiang; Jia-Peng Hu; Frank J Gonzalez; Fei Li
Journal:  Mol Cell Proteomics       Date:  2019-01-07       Impact factor: 5.911

7.  A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity.

Authors:  Dong-Hyun Kim; Zhen Xiao; Sanghoon Kwon; Xiaoxiao Sun; Daniel Ryerson; David Tkac; Ping Ma; Shwu-Yuan Wu; Cheng-Ming Chiang; Edward Zhou; H Eric Xu; Jorma J Palvimo; Lin-Feng Chen; Byron Kemper; Jongsook Kim Kemper
Journal:  EMBO J       Date:  2014-11-25       Impact factor: 11.598

Review 8.  SIRT1 and energy metabolism.

Authors:  Xiaoling Li
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-01       Impact factor: 3.848

Review 9.  Sirtuin 1 deacetylase: a key regulator of hepatic lipid metabolism.

Authors:  Jongsook Kim Kemper; Sung-E Choi; Dong Hyun Kim
Journal:  Vitam Horm       Date:  2013       Impact factor: 3.421

10.  Hepatic sirtuin 1 is dispensable for fibrate-induced peroxisome proliferator-activated receptor-α function in vivo.

Authors:  Jessica A Bonzo; Chad Brocker; Changtao Jiang; Rui-Hong Wang; Chu-Xia Deng; Frank J Gonzalez
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-02-04       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.